Oscar Health, Inc. (NYSE:OSCR – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday . The company traded as high as $30.66 and last traded at $29.53, with a volume of 1130498 shares trading hands. The stock had previously closed at $29.79.
Analyst Upgrades and Downgrades
Several research analysts recently commented on the company. Robert W. Baird raised their target price on Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Wells Fargo & Company set a $20.00 price objective on shares of Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. UBS Group raised their price objective on shares of Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Finally, Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and lifted their target price for the company from $10.00 to $16.00 in a research report on Monday, April 20th. Three analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Oscar Health has an average rating of “Hold” and a consensus price target of $20.78.
View Our Latest Report on OSCR
Oscar Health Price Performance
Oscar Health (NYSE:OSCR – Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.90 billion. During the same quarter last year, the company posted $0.92 EPS. The firm’s revenue for the quarter was up 52.6% on a year-over-year basis. On average, equities research analysts predict that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.
Insider Activity
In other news, insider Adam Mcananey sold 9,859 shares of Oscar Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares in the company, valued at approximately $4,785,026.24. The trade was a 4.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 147,500 shares of the business’s stock in a transaction that occurred on Tuesday, June 23rd. The stock was sold at an average price of $29.38, for a total value of $4,333,550.00. Following the completion of the transaction, the director directly owned 1,360,866 shares in the company, valued at $39,982,243.08. The trade was a 9.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 2,423,470 shares of company stock valued at $69,379,702. Corporate insiders own 25.11% of the company’s stock.
Hedge Funds Weigh In On Oscar Health
Institutional investors have recently bought and sold shares of the business. Jones Financial Companies Lllp boosted its stake in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio acquired a new stake in shares of Oscar Health in the first quarter valued at $30,000. Fifth Third Bancorp increased its stake in shares of Oscar Health by 148.7% in the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after buying an additional 1,413 shares in the last quarter. Quarry LP raised its holdings in shares of Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after buying an additional 1,469 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new position in shares of Oscar Health in the first quarter valued at about $49,000. Institutional investors own 75.70% of the company’s stock.
About Oscar Health
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
Read More
- Five stocks we like better than Oscar Health
- Burger King’s Turnaround Is Putting Restaurant Brands Back in Focus
- Short Squeeze Alert—Moderna Stock Surges on New Strategy
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
